Print Page   |   Sign In   |   Register
Companies: Pressure BioSciences, Inc. (PBIO)

Company Profile


Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.


Contact Information

  • 14 Norfolk Avenue
  • South Easton, MA 02375

Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
Regulatory Agency Financial Industry Regulatory Authority
CIK 0000830656
Fiscal Year End 12/31
OTC Marketplace OTCQB

Profile Data

SIC - Industry Classification 3826 - Analytical instruments
Incorporated In: MA, USA
Year of Inc. 2004
Employees 9 a/o Nov 09, 2014

Company Officers/Contacts

Richard T. Schumacher CEO, President, Acting CFO
Edmund Ting Senior VP, Engineering
Alexander Lazarev VP, R&D
Nathan P. Lawrence VP, Sales & Mktg.

Company Directors

Jeffrey N. Peterson Chairman
Vito J. Mangiardi
Kevin A. Pollack
Michael S. Urdea

Service Providers

Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
United States
Securities Counsel
Lucosky Brookman LLP OTCQX Sponsor
101 Wood Avenue South
5th Floor
United States
Investor Relations Firm

Not Available

Company History

  • Formerly=Boston Biomedica, Inc. until 9-04


Community Search
Sign In